The truth behind this undeniable efficacy - Recurrence rates and relapse risk factors of acne treatment with oral isotretinoin

Dermatology

Volumn 212, Issue 2, 2006, Pages 99-100

  Zouboulis, Christos C ^a,b  

^a DESSAU MEDICAL CENTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE; DESQUAMATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; EDITORIAL; ENDOCRINE DISEASE; FAMILY HISTORY; FOLLOW UP; HUMAN; INFLAMMATION; PREGNANCY; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RECURRENCE RISK; RELAPSE; REMISSION; RISK FACTOR; SEBORRHEA; SEBUM SECRETION; SEX DIFFERENCE;

ACNE VULGARIS; ADMINISTRATION, ORAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; MALE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 32944474458     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090646     Document Type: Editorial

References (15)

1. Peck GL, Olsen TG, Yoder FW, Strauss JS, Downing DT, Pandya M, Butkus D, Arnaud-Battandier J: Prolonged remissions of cystic and conglobate acne with 13-cis retinoic acid. N Engl J Med 1979;300:329-333.
2. Orfanos CE, Zouboulis CC: Oral retinoids in the treatment of seborrhoea and acne. Dermatology 1998;196:140-147.
3. Zouboulis CC, Piquero-Martin J: Update and future of systemic acne treatment. Dermatology 2003;206:37-53.
4. Goldstein JA, Comite H, Mescon H, Pochi PE: Isotretinoin in the treatment of acne: histologic changes, sebum production, and clinical observations. Arch Dermatol 1982;118:555-558.
5. Jones DH, King K, Miller AJ, Cunliffe WJ: A dose-response study of 13-cis-retinoic acid in acne vulgaris. Br J Dermatol 1983;108:333-343.
6. Hennes R, Mack A, Schell H, Vogt HJ: 13-cis-Retinoic acid in conglobate acne: a follow-up study of 14 trial centers. Arch Dermatol Res 1984;276:209-215.
7. Harms M, Masouye I, Radeff B: The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study. Dermatologica 1986;172:148-153.
8. Cunliffe WJ, Norris JF: Isotretinoin - An explanation for its long-term benefit. Dermatologica 1987;175(suppl 1):133-137.
9. Chivot M, Midoun H: Isotretinoin and acne - A study of relapses. Dermatologica 1990;180:240-243.
10. Goulden V, Clark SM, McGeown C, Cunliffe WJ: Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997;137:106-108.
11. Lehucher-Ceyrac D, Weber-Buisset MJ: Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology 1993;186:123-128.
12. Layton AM, Knaggs H, Taylor J, Cunliffe WJ: Isotretinoin for acne vulgaris - 10 years later: a safe and successful treatment. Br J Dermatol 1993;129:292-296.
13. Shahidullah M, Tham SN, Goh CL: Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore. Int J Dermatol 1994;33:60-63.
14. Lehucher-Ceyrac D, de La Salmoniere P, Chastang C, Morel P: Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients. Dermatology 1999;198:278-283.
15. Quéreux G, Volteau C, Nguyen JM, Dréno B: Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology 2006;212:168-176.